We are live on ! Find out more
DF

DC Funds Portfolio holdings

AUM $1.49M
1-Year Est. Return 18.57%
This Fund
S&P 500
This Quarter Est. Return
-37.14%
1 Year Est. Return
-18.57%
3 Year Est. Return
-38.34%
5 Year Est. Return
-87.14%
10 Year Est. Return
AUM
$6.02M
AUM Growth
-$4.33M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCRX icon
1
TScan Therapeutics
TCRX
$48.6M
$3.69M 61.2%
630,000
HOWL icon
2
Werewolf Therapeutics
HOWL
$17.2M
$1.44M 23.87%
589,102
BRNS
3
Barinthus Biotherapeutics
BRNS
$22.8M
$899K 14.93%
642,204

Similar funds

DC Funds's Q2 2024 Portfolio in Review

As of Q2 2024, DC Funds held 3 positions worth $6.02M, down 42% from $10.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 0%. DC Funds opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • DC Funds's ten largest holdings make up 100% of its $6.02M portfolio in Q2 2024.
  • DC Funds opened 0 new positions and closed 0 in Q2 2024.
  • DC Funds's portfolio value fell 42% quarter-over-quarter to $6.02M.

Based on DC Funds's 13F filing for Q2 2024, filed 13 Aug 2024.